MedPath

Evaluation of the effect of vitamin B12 on neuropathy in diabetic patients of Razi Hospital in Birjand in 2023

Phase 3
Conditions
Diabetic neuropathy.
Diabetes mellitus due to underlying condition with diabetic autonomic (poly)neuropathy
E08.43
Registration Number
IRCT20190618043934N24
Lead Sponsor
Birjand University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
80
Inclusion Criteria

Patient satisfaction to enter the study
Having diabetes for more than a year

Exclusion Criteria

Having an underlying disease such as myositis
Having connective tissue and joint disease
Limb amputation
Having autoimmune disease
Having severe osteoarthritis
Malignancy
Having fibromyalgia
Having kidney and liver failure
Patients with ESRD
Prolonged diabetes
Having vertebral discopathy
Having anemia
Having hypothyroidism
Drug use

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain. Timepoint: Before the intervention and 3 months after the intervention. Method of measurement: Using the audio-visual pain scale questionnaire.;Symptoms and severity of neuropathy. Timepoint: Before the intervention and 3 months after the intervention. Method of measurement: By Using Nerve conduction velocity.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath